Zynex, Inc., through its subsidiaries, designs, manufactures, and markets medical devices to treat chronic and acute pain; and activate and exercise muscles for rehabilitative purposes with electrical stimulation.
Growing Profit Margin: ZYXI's current net profit margins (22.6%) are lower than last year (33.3%).
Past Earnings Growth Analysis
Earnings Trend: ZYXI has become profitable over the past 5 years, growing earnings by 71.6% per year.
Accelerating Growth: ZYXI's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: ZYXI had negative earnings growth (-10.5%) over the past year, making it difficult to compare to the Medical Equipment industry average (28.3%).
Return on Equity
High ROE: ZYXI's Return on Equity (55.9%) is considered outstanding.
What is Zynex's current dividend yield, its reliability and sustainability?
Dividend Yield vs Market
Current dividend yield vs market & industry
Notable Dividend: Unable to evaluate ZYXI's dividend yield against the bottom 25% of dividend payers, as the company has not reported any payouts.
High Dividend: Unable to evaluate ZYXI's dividend yield against the top 25% of dividend payers, as the company has not reported any payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if ZYXI's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if ZYXI's dividend payments have been increasing.
Current Payout to Shareholders
Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of ZYXI's dividend in 3 years as they are not forecast to pay a notable one for the US market.
What is the CEO of Zynex's salary, the management and board of directors tenure and is there insider trading?
1.7yrs
Average management tenure
CEO
ThomasSandgaard(60yo)
23.9yrs
Tenure
US$1,085,475
Compensation
Mr. Thomas Sandgaard founded Zynex, Inc. in 1996 and has been its Chairman, Chief Executive Officer and President since 1996. Mr. Sandgaard served as the Chief Financial Officer and Chief Accounting Office ...
CEO Compensation Analysis
Compensation vs Market: Thomas's total compensation ($USD1.09M) is below average for companies of similar size in the US market ($USD1.71M).
Compensation vs Earnings: Thomas's compensation has increased by more than 20% whilst company earnings have fallen more than 20% in the past year.
Management Age and Tenure
1.7yrs
Average Tenure
Experienced Management: ZYXI's management team is not considered experienced ( 1.7 years average tenure), which suggests a new team.
Board Age and Tenure
1.9yrs
Average Tenure
60.5yo
Average Age
Experienced Board: ZYXI's board of directors are not considered experienced ( 1.9 years average tenure), which suggests a new board.
Insider Trading
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Recent Insider Transactions
SellUS$1,038,00020 Aug 19
Thomas Sandgaard
Entity
Individual
Role
Chief Executive Officer
Founder
Shares
100,000
Max Price
US$10.38
SellUS$30,93812 Jun 19
Daniel Moorhead
Entity
Individual
Role
Chief Financial Officer
Chief Financial Officer
Shares
3,750
Max Price
US$8.25
SellUS$1,844,02507 Jun 19
Thomas Sandgaard
Entity
Individual
Role
Chief Executive Officer
Founder
Shares
218,000
Max Price
US$8.57
SellUS$179,15314 May 19
Daniel Moorhead
Entity
Individual
Role
Chief Financial Officer
Chief Financial Officer
Shares
25,000
Max Price
US$7.24
SellUS$211,46221 Mar 19
Thomas Sandgaard
Entity
Individual
Role
Chief Executive Officer
Founder
Shares
48,008
Max Price
US$4.41
Ownership Breakdown
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Management Team
Thomas Sandgaard (60yo)
Founder
Tenure: 23.9yrs
Compensation: US$1.09m
Chris Brown
Vice President of Sales & Marketing
Tenure: 0.8yrs
Dan Moorhead (47yo)
Chief Financial Officer
Tenure: 2.5yrs
Compensation: US$404.18k
Joachim Sandgaard
Information Systems Manager
Tenure: 0yrs
Compensation: US$92.00k
Giuseppe Papandrea
Chief Operating Officer
Tenure: 0.4yrs
Board Members
Barry Michaels (69yo)
Director
Tenure: 1.9yrs
Compensation: US$116.25k
Thomas Sandgaard (60yo)
Founder
Tenure: 23.9yrs
Compensation: US$1.09m
Michael Cress (61yo)
Director
Tenure: 1.9yrs
Compensation: US$106.52k
Josh Disbrow (44yo)
Independent Director
Tenure: 1.8yrs
Compensation: US$113.08k
Company Information
Zynex, Inc.'s company bio, employee growth, exchange listings and data sources
Zynex, Inc., through its subsidiaries, designs, manufactures, and markets medical devices to treat chronic and acute pain; and activate and exercise muscles for rehabilitative purposes with electrical stim ...
Company Analysis and Financial Data Status
All financial data provided by Standard & Poor's Capital IQ.
Data
Last Updated (UTC time)
Company Analysis
2019/12/06 00:12
End of Day Share Price
2019/12/05 00:00
Earnings
2019/09/30
Annual Earnings
2018/12/31
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.